Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice

Aging

Volumn 8, Issue 4, 2016, Pages 664-684

  Griñán Ferré, Christian ^a   Sarroca, Sara ^b   Ivanova, Aleksandra ^a   Puigoriol Illamola, Dolors ^a   Aguado, Fernando ^a   Camins, Antoni ^a   Sanfeliu, Coral ^b   Pallàs, Mercè ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Alzheimer disease; Behavior; Cognition; Deacetylase; Methyltransferase; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); AMYLOID PRECURSOR PROTEIN; PEPTIDE FRAGMENT;

AGING; ALZHEIMER DISEASE; ANIMAL; BRAIN; COGNITIVE DEFECT; DISEASE MODEL; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOUSE; OXIDATIVE STRESS; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; COGNITION DISORDERS; COGNITIVE DYSFUNCTION; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; MICE; MICE, TRANSGENIC; OXIDATIVE STRESS; PEPTIDE FRAGMENTS;

EID: 85017297399     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100906     Document Type: Article

References (55)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005; 366:2112-2117
2. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. Rao AT, Degnan. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013; 9:63-75.e2
3. Zanetti O, Solerte SB, Cantoni. Life expectancy in Alzheimer's disease (AD). Arch Gerontol Geriatr. 2009; 49 Suppl 1:237-243
4. World Health Organization report. 2011
5. Roberson ED, Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science. 2006; 314:781-784
6. Avramopoulos D. Genetics of Alzheimer's disease: recent advances. Genome Medicine. 2009; 1:34
7. Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, Jehu L, Segurado R, Stone D, Schadt E, Karnoub M, Nowotny P, Tacey K, Catanese J, Sninsky J, Brayne C, Rubinszteing D, Gill M, Lawlor B, Lovestone S, Holmans P, O'Donovan M, Morris JC, Thal L, Goate A, Owen MJ. and Williams, J. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Human Molecular Genetics. 2007; 16:865-873
8. Harold D, Abraha R, Hollingworth P, Sims R, Gerrish A, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009; 41:1088-1093
9. Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BB, et al. Common variants at MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics. 2011; 43:436-441
10. Genin E, Hannequin D, Wallon D, Sleegers K, Hiltunen M, et al. APOE and Alzheimer Disease: A Major Gene with Semi-Dominant Inheritance. Molecular psychiatry. 2011; 16:903-907
11. Mohandas E, Rajmohan V, and Raghunath B. Neurobiology of Alzheimer's disease. Indian Journal of Alzheime's Disease. 2009; 21:1077-1087
12. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007; 39:17-23
13. Bertram L. Alzheimer's disease genetics: Current status and future perspectives. Alzheimer's and Dementia. 2009; 5:147
14. Bettens K, Sleegers K, and Van Broeckhoven C. Current status on Alzheimer disease molecular genetics: from past, to present, to future. Hum. Mol. Gent. 2010; ddq142
15. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suñer D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu Y-Z, Plass C, and Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102:10604-10609
16. Mastroeni D, McKee A, Grover A, Rogers J, and Coleman PD. Epigenetic Differences in Cortical Neurons from a Pair of Monozygotic Twins Discordant for Alzheimer's Disease. PloS ONE. 2009; 4e6617
17. Millan MJ. The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? Dialogues Clin Neurosci. 2014.16:373-393
18. Bradley-Whitman MA and Lovell MA. Mech Aging Dev. 2013; 134:486-495. Doi: 10.1016/j.mad.2013.08.005
19. Zhenyun Yuan, Mingwei Wang, Baoyong Yan, Ping Gu, Xiangming Jiang, Xiufen Yang, and Dongsheng Cui. An enriched environment improves cognitive performance in mice from the senescence-accelerated prone mouse 8 strain. Neural Regen Res. 2012; 7:1797-1804
20. Griñan-Ferré C, Pérez-Cáceres D, Martínez Gutiérrez-Zetina S, Camins A, Palomera-ávalos V, Ortuño-Sahagún D, Teresa-Rodrigo MT, Pallàs M. Environmental Enrichment Improves Behavior, Cognition, and Brain Functional Markers in Young Senescence-accelerated Prone Mice (SAMP8). Molecular Neurobiology. 2015; DOI:10.1007/s12035-015-9210-6
21. Kaminski Z, Wang SC, Petronisa. Complex disease, gender and epigenetics. Annals of Medicine. 2006; 38:530-544
22. West et al. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J Mol Neurosci. 1995; 6:141-146
23. Fuso A, Seminara L, Cavallaro RA, D'Anselmi F, Scarpa S. Sadenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci. 2005; 28:195-204
24. Chaudhry U, Zhuang H, Doré S Microsomal prostaglandin E synthase-2: cellular distribution and expression in Alzheimer's disease. Exp Neurol. 2010; 223:359-365
25. Rao, JS, Keleshian VL, Klein S, and Rapoport Sl. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Translational Psychiatry. 2012; 2: e132
26. Fleming JL, Phiel CJ, Toland AE. The role for oxidative stress in aberrant DNA methylation in Alzheimer's disease. Curr Alzheimer Res. 2012; 9:1077-96
27. Coppieters N, Dragunow M. Epigenetics in Alzheimer's disease: a focus on DNA modifications. Curr Pharm Des. 2011; 17:3398-3412
28. Zhang C, McNeil E, Dressler L, Siman R. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp Neurol. 2007; 204:77-87
29. Chang EH, Savage MJ, Flood DG, Thomas JM, Levy RB, Mahadomrongkul V, Shirao T, Aoki C, Huerta PT. AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc Natl Acad Sci U S A. 2006; 103:3410-3415
30. Andrew J Bannister and Tony Kouzarides. Regulation of chromation by histone modifications. Cell Res. 2011; 21:381-395
31. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic mechanisms in Alzheimer's disease. 2011; Neurobiol Aging. 32:1161-80. Doi.1016/j.neurobiolaging.2010.08. 017
32. Afanas'ev I. Mechanisms of superoxide signaling in epigenetic processes: relation to aging and cancer. Aging Dis. 2015; 6:216-227
33. Jaszberenyi M, Rick FG, Szalontay L, Block NL, Zarandi M, Cai RZ, Schally AV. Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease. Aging (Albany NY). 2012; 4:755-767
34. Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2012; 33:196.e29-24
35. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. Journal of Neuroscience. 2006; 26:10129-10140
36. Saul A, Sprenger F, Bayer TA, Wirths O. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease. Neurobiol Aging. 2013; 34:2564-2573
37. Kanno T, Tsuchiya A, Nishizaki T. Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice. Behav Brain Res. 2014; 274:302-306
38. Rojas S, Herance JR, Gispert JD, Abad S, Torrent E, Jiménez X, Pareto D, Perpiña U, Sarroca S, Rodríguez E, Ortega-Aznar A, Sanfeliu C. In vivo evaluation of amyloid deposition and brain glucose metabolism of 5XFAD mice using positron emission tomography. Neurobiol Aging. 2013; 34:1790-1798
39. Yang E-J, Ahn S, Ryu J, Choi M-S, Choi S, Chong YH, et al. Phloroglucionol Attenuates the Cognitive Deficits of the 5XFAD mouse Model of Alzheimer's Disease. 2015; PLos ONE 10: e0135686. Doi 10.1371/journal.pone.0135686
40. Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's diseasae brain: potential causes and consequences involving amyloid b-peptide-associated free radical oxidative stress. Free Radic Biol Med. 2002; 32:1050-1060
41. Chouliaras L, Kenis G, Visser PJ, Scheltens P, Tsolaki M, Jones RW, Kehoe PG, Graff C, Girtler NG, Wallin ÅK, Rikkert MO, Spiru L, Elias-Sonnenschein LS, Ramakers IH, Pishva E, van Os J, Steinbusch HW, Verhey FR, van den Hove DL, Rutten BP. DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts. Epigenomics. 2015; 7:533-537
42. Córdova-Palomera A, Fatjó-Vilas M, Kebir O, Gastó C, Krebs MO, Fañanás L. Polymorphic variation in the epigenetic gene DNMT3B modulates the environmental impact on cognitive ability: a twin study. Eur Psychiatry. 2015; 30:303-308
43. Su, SC, Tsai, LH. DNA methylation in cognition comes of age. Nature Neuroscience. 2012; 15:1061-1062
44. Chicas A, Kapoor A, Wang X, Aksoy O, Evertts AG, Zhang MQ, Garcia BA, Bernstein E, Lowe SW. H3K4 demethylation by Jard1a and Jard1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc Natl Acad Sci USA. 2012; 109: 897-896
45. DiTacchio, L, Le HD, R Vollmers C, Hatori M, Witcher M, Secombe J, Panda S. Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock Science. 2011; 333:1881-1885
46. Schweizer S, Harms C, Lerch H, Flynn J, Hecht J, Yildirim F, Meisel A, Märschenz S. J Cereb Blood Flow Metab. 2015; 350:1640-1647
47. Penney J, Tsai LH. Histone deacetylases in memory and cognition. Sci Signal. 2014; 7:re12
48. Duan W. Sirtuins: from metabolic regulation to brain aging. Front Aging Neurosci. 2013; 5:36
49. Cardinale A, de Stefano MC, Mollinari C, Racaniello M, Garaci E, Merlo D. Biochemical characterization of sirtuin 6 in the brain and its involvement in oxidative stress response. Neurochem Res. 2015; 40:59-56
50. KanfiY., Naiman S., Amir G., Peshti V., Zinman G., Nahum L., Bar-Joseph Z, Cohen HY. The sirtuin SIRT6 regulates lifespan in male mice. Nature. 2012; 483:218-221
51. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature. 2009; 459:55-60
52. Pellow S, Chopin P, File SE and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 1985; 14:149-167
53. Hall, C. S. Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. Journal of Comparative Psychology. 1934; 18:385-403
54. Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. Behavioral data. Behav Brain Res. 1988; 31:47-59
55. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Charles V Vorhees and Michael T Williams. Nat Protoc. 2006; 1:848-858.doi:10.1038/nprot.2006.116